Published in Biochim Biophys Acta on October 17, 1980
Resistance to chemotherapeutic antimetabolites: a function of salvage pathway involvement and cellular response to DNA damage. Br J Cancer (1997) 0.95
Nucleoside salvage and resistance to antimetabolite anticancer agents. Br J Cancer (1991) 0.87
Metabolomics identifies pyrimidine starvation as the mechanism of 5-aminoimidazole-4-carboxamide-1-β-riboside-induced apoptosis in multiple myeloma cells. Mol Cancer Ther (2013) 0.81
Stress response protein (srp-27) determination in primary human breast carcinomas: clinical, histologic, and prognostic correlations. J Natl Cancer Inst (1991) 3.07
Acute and nonacute complications associated with interscalene block and shoulder surgery: a prospective study. Anesthesiology (2001) 2.61
Endoscopic papillary balloon dilation vs. sphincterotomy for removal of common bile duct stones: a prospective randomized pilot study. Endoscopy (2001) 2.07
Comprehensive microRNA expression profiling of the hematopoietic hierarchy. Proc Natl Acad Sci U S A (2010) 1.67
The relationship between juxtapapillary duodenal diverticula and disorders of the biliopancreatic system: analysis of 350 patients. Gastrointest Endosc (2001) 1.63
Long-term results (7 to 10 years) of endoscopic papillotomy for choledocholithiasis. Multivariate analysis of prognostic factors for the recurrence of biliary symptoms. Gastrointest Endosc (1998) 1.60
Presentation and physical evaluation of RadioVisioGraphy. Oral Surg Oral Med Oral Pathol (1989) 1.58
Improved tumor staging by diagnostic laparoscopy. Z Gastroenterol (1999) 1.58
Immunogenicity of two accelerated hepatitis B vaccination protocols in liver transplant candidates. Eur J Gastroenterol Hepatol (2001) 1.48
Pancreatic endoscopic sphincterotomy in patients with chronic pancreatitis: a single-center experience in 171 consecutive patients. Endoscopy (2002) 1.47
Long-term follow-up of patients with iron deficiency anemia after a close endoscopic examination of the upper and lower gastrointestinal tract. Z Gastroenterol (2000) 1.41
Efficacy of intraoral topical anesthetics in children. J Dent (2005) 1.40
The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast. Oncogene (1992) 1.34
A new HF current generator with automatically controlled system (Endocut mode) for endoscopic sphincterotomy--preliminary experience. Endoscopy (1998) 1.30
Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding. Gastroenterology (1997) 1.20
Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients. J Clin Oncol (1998) 1.19
A role for both Ets and C/EBP transcription factors and mRNA stabilization in the MAPK-dependent increase in p21 (Cip-1/WAF1/mda6) protein levels in primary hepatocytes. Mol Biol Cell (2000) 1.16
Estrogen-induced post-transcriptional modulation of c-myc proto-oncogene expression in human breast cancer cells. J Biol Chem (1988) 1.15
An analysis of 1539 patients with cancer of unknown primary site. Cancer (1986) 1.11
Enhanced 5-fluorouracil nucleotide formation after methotrexate administration: explanation for drug synergism. Science (1979) 1.11
Determination of protein by a modified Lowry procedure in the presence of some commonly used detergents. Anal Biochem (1979) 1.09
Modulation of 5-fluorouracil metabolism and cytotoxicity by antimetabolite pretreatment in human colorectal adenocarcinoma HCT-8. Cancer Res (1981) 1.07
Role of Rho protein in lovastatin-induced breakdown of actin cytoskeleton. J Pharmacol Exp Ther (1997) 1.04
Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study. J Hepatol (1997) 1.02
Acute ulcer bleeding. A prospective randomized trial to compare Doppler and Forrest classifications in endoscopic diagnosis and therapy. Dig Dis Sci (1997) 1.01
Survival of women with metastatic breast cancer at Yale from 1920 to 1980. J Clin Oncol (1983) 1.00
Electrohydraulic lithotripsy treatment of gallstone after disimpaction of the stone from the duodenal bulb (Bouveret's syndrome). Ital J Gastroenterol Hepatol (1999) 1.00
The influence of methotrexate pretreatment on 5-fluorouracil metabolism in L1210 cells. J Biol Chem (1981) 0.97
Prognostic and predictive significance of ErbB-2 breast tumor levels measured by enzyme immunoassay. J Clin Oncol (2001) 0.95
Noninvasive spectroscopic analysis of fluoropyrimidine metabolism in cultured tumor cells. Cancer Res (1986) 0.94
Enhancement of 5-fluorouracil antitumor effects by the prior administration of methotrexate. Pharmacol Ther (1989) 0.92
Endoscopic biliary stenting for the palliation of pancreatic cancer: results, survival predictive factors, and comparison of 10-French with 11.5-French gauge stents. Am J Gastroenterol (1996) 0.91
Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines. Cancer Res (1986) 0.91
Treatment of difficult intrahepatic stones by using extracorporeal and intracorporeal lithotripsy techniques: 10 years' experience in 55 patients. Scand J Gastroenterol (1999) 0.90
An HPLC assay and a microbiological assay to determine levofloxacin in soft tissue, bone, bile and serum. J Pharm Biomed Anal (2001) 0.89
Enhancement of 1-beta-D-arabinofuranosylcytosine accumulation within L1210 cells and increased cytotoxicity following thymidine exposure. Cancer Res (1980) 0.89
Tamoxifen and 5-fluorouracil in breast cancer: cytotoxic synergism in vitro. Cancer Res (1983) 0.89
Adverse effects of nonsteroidal anti-inflammatory drugs on the small and large bowel. Endoscopy (1999) 0.88
Levels of thymidylate synthetase during normal culture growth of L1210 cells. Cancer Res (1986) 0.86
Biochemical and cytokinetic modulation of L1210 and HL-60 cells by hydroxyurea and effect on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity. Cancer Res (1983) 0.86
Inhibition of growth of leukemic cells by inhibitors of calmodulin: phenothiazines and melittin. Cancer Chemother Pharmacol (1985) 0.85
Use of periodate and methylamine for the quantitation of intracellular 5-fluoro-2'-deoxyuridine-5'-monophosphate by high-performance liquid chromatography. J Chromatogr (1981) 0.85
Endoscopic therapy of adenomas of the papilla of Vater. A retrospective analysis with long-term follow-up. Dig Liver Dis (2000) 0.84
Optimal schedule of methotrexate and 5-fluorouracil in human breast cancer. Cancer Res (1982) 0.84
Downregulation of ileal bile acid absorption in bile-duct-ligated rats. J Hepatol (2000) 0.84
Root substance removal with Er:YAG laser radiation at different parameters using a new delivery system. J Periodontol (2000) 0.84
The role of serum liver enzymes in the diagnosis of choledocholithiasis. Hepatogastroenterology (2001) 0.83
Factors influencing the career choices of physicians trained at Yale-New Haven Hospital from 1929 through 1994. Acad Med (1998) 0.83
The association of p53 immunopositivity with tumor proliferation and other prognostic indicators in breast cancer. Mod Pathol (1994) 0.83
Combination therapy for diffuse histiocytic lymphoma that includes antimetabolites. Cancer Treat Rep (1977) 0.83
Molecular lesions involved in the progression of a human breast cancer. Oncogene (1988) 0.82
Impaired response to pneumococcal vaccine in Hodgkin's disease. N Engl J Med (1978) 0.82
Accelerated schedule of hepatitis B vaccination in liver transplant candidates. Transplant Proc (1998) 0.82
Who will determine the future of academic medicine? Clin Res (1986) 0.82
Pulmonary metastases in ovarian cancer. Analysis of 357 patients. Cancer (1985) 0.81
Influence of cholestasis on absorption of ursodeoxycholic acid. Dig Dis Sci (1999) 0.81
Mechanism of synergistic cell killing when methotrexate precedes cytosine arabinoside: study of L1210 and human leukemic cells. J Clin Invest (1979) 0.80
High-quality Si3N4 circuits as a platform for graphene-based nanophotonic devices. Opt Express (2013) 0.80
Schedule-dependent cytotoxicity of methotrexate and 5-fluorouracil in human colon and breast tumor cell lines. J Clin Invest (1980) 0.80
5'-Deoxy-5-fluorouridine selective toxicity for human tumor cells compared to human bone marrow. Cancer Res (1983) 0.79
First case of isolated small bowel transplantation at the university of cologne: rejection-free course under quadruple immunosuppression and endoluminal monitoring with video-capsule. Transplant Proc (2004) 0.79
Early and late events in the development of human breast cancer. Basic Life Sci (1991) 0.79
Sclerosing variants of follicular center cell lymphomas presenting in the retroperitoneum. Cancer (1983) 0.78
The presence of phospholipase A and lysophospholipase activities in culture supernatant fluid from Alteromonas espejiana. Int J Biochem (1983) 0.78
Use of high-dose oral methotrexate sequenced at 24 hours with 5-FU: a clinical toxicity study. Cancer Treat Rep (1983) 0.78
Tamoxifen and 5-fluorouracil in breast cancer: modulation of cellular RNA. Cancer Res (1983) 0.78
[Laparoscopic tumor staging in gastrointestinal carcinomas: significance of internal medicine laparoscopy]. Z Gastroenterol (2001) 0.78
[Various physical parameters of toothbrushing and their relation to the appearance of non-inflammatory gingival recession]. ZWR (1987) 0.78
Modulation of fluoropyrimidine metabolism in L1210 cells by L-alanosine. Biochem Pharmacol (1983) 0.77
[Schonlein-Henoch syndrome with severe abdominal involvement in an adult]. Dtsch Med Wochenschr (1996) 0.77
Altered 5-azacytidine metabolism following 3-deazauridine treatment of L5178Y and human myeloblasts. Cancer Res (1980) 0.77
Thymidine enhancement of methotrexate and 5-fluorouracil toxicity in cultured human colon carcinoma. Cancer Chemother Pharmacol (1984) 0.77
Sequential infusions of methotrexate and 5-fluorouracil in advanced cancer: pharmacology, toxicity, and response. Cancer Res (1985) 0.77
[Percutaneous transhepatic cholangioscopy (PTCS)--an important supplement in diagnosis and therapy of biliary tract diseases (indications, technique and results)]. Z Gastroenterol (1995) 0.76
A follow-up of a randomized study comparing two chemotherapy treatments for advanced diffuse histiocytic lymphoma. J Clin Oncol (1984) 0.76
Randomized study comparing chemotherapy with and without estrogen priming in advanced breast-cancer. Int J Oncol (1994) 0.76
Biochemical alterations during unperturbed suspension growth of L1210 cells. Cancer Res (1981) 0.76
[Severe complications in diagnostic laparoscopy. 9 years experience in 747 examinations]. Med Klin (Munich) (1996) 0.76
Mechanism of hepatoprotective action of bile salts in liver disease. Gastroenterol Clin North Am (1999) 0.76
Synthesis and in vitro characterization of novel amino terminally modified oxotremorine derivatives for brain muscarinic receptors. J Med Chem (1992) 0.76
[Endoscopic laser lithotripsy for difficult calculi after unsuccessful extracorporeal shock wave lithotripsy]. Arq Gastroenterol (1997) 0.76
Pyrazofurin enhancement of 5-azacytidine antitumor activity in L5178Y and human leukemia cells. Cancer Res (1978) 0.76
Minilaparoscopy versus conventional laparoscopy in the diagnosis of hepatic diseases. Gastrointest Endosc (2001) 0.76
Endoscopic stenting in obstructive jaundice due to liver metastases: does it have a benefit for the patient? Hepatogastroenterology (1997) 0.76
Preliminary report on the efficacy of sequential methotrexate and 5-fluorouracil in advanced breast cancer. Cancer (1981) 0.76
Modulation of fluoropyrimidine metabolism by chlorpromazine. Biochem Biophys Res Commun (1986) 0.76
[RadioVisioGraphie--system for film-free intraoral radiographs]. Dtsch Zahnarztl Z (1989) 0.75
One-year clinical evaluation of composite fillings and inlays in posterior teeth. Clin Oral Investig (1997) 0.75